Compare OCGN & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | DIN |
|---|---|---|
| Founded | 2013 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 326.8M |
| IPO Year | 2014 | 1994 |
| Metric | OCGN | DIN |
|---|---|---|
| Price | $1.76 | $27.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | $9.75 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 10.7M | 339.2K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.98% |
| EPS Growth | ★ 31.58 | N/A |
| EPS | N/A | ★ 1.11 |
| Revenue | N/A | ★ $879,300,000.00 |
| Revenue This Year | N/A | $3.71 |
| Revenue Next Year | $1,718.38 | $0.64 |
| P/E Ratio | ★ N/A | $22.97 |
| Revenue Growth | N/A | ★ 8.25 |
| 52 Week Low | $0.57 | $18.63 |
| 52 Week High | $2.73 | $39.68 |
| Indicator | OCGN | DIN |
|---|---|---|
| Relative Strength Index (RSI) | 44.17 | 45.63 |
| Support Level | $1.47 | $23.19 |
| Resistance Level | $1.88 | $29.06 |
| Average True Range (ATR) | 0.18 | 1.28 |
| MACD | -0.06 | 0.11 |
| Stochastic Oscillator | 4.48 | 53.50 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.